Systemic administration of local anesthetic agents to relieve neuropathic pain
about
Drug therapy for chronic idiopathic axonal polyneuropathyThe lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain.Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment).Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral NeuropathyMexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.Ranolazine attenuates behavioral signs of neuropathic pain.Merging Structural Motifs of Functionalized Amino Acids and α-Aminoamides Results in Novel Anticonvulsant Compounds with Significant Effects on Slow and Fast Inactivation of Voltage-gated Sodium Channels and in the Treatment of Neuropathic Pain.Interventional management of neuropathic pain: NeuPSIG recommendations.Phase 1A safety assessment of intravenous amitriptylineNovel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathyDrug therapy for chronic idiopathic axonal polyneuropathy.Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review.Intravenous administration of lidocaine directly acts on spinal dorsal horn and produces analgesic effect: An in vivo patch-clamp analysis.Use of sensory methods for detecting target engagement in clinical trials of new analgesics.Neurological perspectives on voltage-gated sodium channels.Systematic review of management of chronic pain after surgery.Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine.Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine.Neuropathic Pain Related with Spinal Disorders: A Systematic Review.Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.Ketamine could aggravate central nervous toxicity of lidocaine in rats convulsive model.Supraspinal modulation of neuronal synchronization by nociceptive stimulation induces an enduring reorganization of dorsal horn neuronal connectivity.Intravenous Lignocaine Infusion for Intractable Pain in Ewing's Sarcoma.Effect of intravenous lidocaine infusion on long-term postoperative pain after spinal fusion surgery.Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration.Lidocaine-Midazolam-Fentanyl Combination in Controlling Pain for Reduction of Anterior Shoulder Dislocation; a Randomized Clinical Trial.Guidelines for Recognition, Assessment and Treatment of Pain
P2860
Q24247228-EF7C2F43-302D-44EE-AC95-0EA70B90296EQ27316372-E56F2F00-96B3-4741-ADAE-A326E8E50945Q33519422-B3D800D0-B3D2-4CC6-B669-D05407B5CF3FQ33552212-A8870079-A131-4E40-8841-407845FC16EEQ34402820-E9193AC2-869F-4EA7-89BF-E430EB37F3DCQ34612092-3B57F629-6E09-47C6-9DC9-5ABD6D5F89E0Q35099293-E94EEF55-BEF9-490F-95E0-7027F3E392B8Q35794710-3810C321-40D8-46BD-AF4C-252BD58A9BE8Q36026833-D69F5D36-6CA1-41FA-A09A-E4A967506999Q36329924-87BD9D65-813D-4099-9787-A4731E8A9379Q36410068-3985C39B-C640-4C37-978B-38824E69B399Q36518642-F5446F22-9579-4C4E-8CFF-A3543CE7AD5EQ36910574-951F0E16-290B-47D4-A2B5-24C849317965Q37605357-2EC2EF58-F204-4FBC-A1C9-E788499B49FCQ38042001-8FFE5206-7DB7-4B8A-B71F-9325594C5F70Q38691471-C86BB0DF-86C9-46DF-8224-979CF6368095Q40376134-79AA4855-90DA-4E4C-9A9B-CEC6F39F5804Q41126715-5EE80FD8-77A0-4001-BB42-8722525E6E6FQ41539243-8FC23750-F582-4B26-91C5-B25FFAC37C3FQ43075662-F8B02C95-F40E-4A7A-B00E-10BA1BAEEB27Q43075742-0C6E84AB-E5ED-4652-B622-0CE842BE9401Q43120225-BCB74BDF-E715-43AE-A8B9-10068AE574F4Q49937432-8D78ADFE-AA42-4615-AB7E-E070D1C5FAB6Q50025348-38D602A0-AEB8-4DF6-BA14-C89F30068A06Q52622899-DF7DB2AE-D61C-4A9E-B425-F51E2E6F8738Q53076836-4A9135F7-D1D4-4618-8BBB-161D64B4E470Q55602294-278FDF35-F3CD-4295-97CD-747531B80CB6Q57318961-AF668570-EABE-4DD4-B779-A57FB393C9DE
P2860
Systemic administration of local anesthetic agents to relieve neuropathic pain
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Systemic administration of local anesthetic agents to relieve neuropathic pain
@ast
Systemic administration of local anesthetic agents to relieve neuropathic pain
@en
Systemic administration of local anesthetic agents to relieve neuropathic pain
@en-gb
Systemic administration of local anesthetic agents to relieve neuropathic pain
@nl
type
label
Systemic administration of local anesthetic agents to relieve neuropathic pain
@ast
Systemic administration of local anesthetic agents to relieve neuropathic pain
@en
Systemic administration of local anesthetic agents to relieve neuropathic pain
@en-gb
Systemic administration of local anesthetic agents to relieve neuropathic pain
@nl
prefLabel
Systemic administration of local anesthetic agents to relieve neuropathic pain
@ast
Systemic administration of local anesthetic agents to relieve neuropathic pain
@en
Systemic administration of local anesthetic agents to relieve neuropathic pain
@en-gb
Systemic administration of local anesthetic agents to relieve neuropathic pain
@nl
P2093
P2860
P3181
P1476
Systemic administration of local anesthetic agents to relieve neuropathic pain
@en
P2093
E D McNicol
I W Tremont-Lukats
V Challapalli
P2860
P304
P3181
P356
10.1002/14651858.CD003345.PUB2
P577
2005-10-19T00:00:00Z